Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

EVG

Evgen Pharma (EVG)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG
DataOraFonteTitoloSimboloCompagnia
08/12/202115:08UK RegulatoryEvgen Pharma PLC Grant of OptionsLSE:EVGEvgen Pharma Plc
07/12/202122:49Alliance NewsAlliance NewsEARNINGS UPDATES: Carr's beats expectations; Premier assets hit recordLSE:EVGEvgen Pharma Plc
07/12/202107:59UK RegulatoryEvgen Pharma PLC Half-year ReportLSE:EVGEvgen Pharma Plc
23/11/202108:00UK RegulatoryEvgen Pharma PLC Notice of ResultsLSE:EVGEvgen Pharma Plc
10/11/202119:22Alliance NewsAlliance NewsTRADING UPDATES: Permanent TSB sells loan portfolio; Dekel output upLSE:EVGEvgen Pharma Plc
10/11/202108:00RNS Non-RegulatoryEvgen Pharma PLC Publication of data on SFX-01 in glioblastomaLSE:EVGEvgen Pharma Plc
19/10/202115:39UK RegulatoryEvgen Pharma PLC Holding(s) in CompanyLSE:EVGEvgen Pharma Plc
20/09/202115:50Alliance NewsAlliance NewsIN BRIEF: Evgen Pharma's SFX-01 effective on tumour cellsLSE:EVGEvgen Pharma Plc
20/09/202108:00RNS Non-RegulatoryEvgen Pharma PLC Publication of data in glioblastoma cellsLSE:EVGEvgen Pharma Plc
02/09/202115:06UK RegulatoryEvgen Pharma PLC Second Price Monitoring ExtnLSE:EVGEvgen Pharma Plc
02/09/202115:00UK RegulatoryEvgen Pharma PLC Price Monitoring ExtensionLSE:EVGEvgen Pharma Plc
02/09/202112:56Alliance NewsAlliance NewsIN BRIEF: Evgen SFX-01 granted orphan drug designation by US FDALSE:EVGEvgen Pharma Plc
02/09/202112:46Dow Jones NewsEvgen Pharma Climbs on FDA Orphan-Drug Designation for Brain Tumor TreatmentLSE:EVGEvgen Pharma Plc
02/09/202112:01UK RegulatoryEvgen Pharma PLC Glioma Orphan Drug designation granted by FDALSE:EVGEvgen Pharma Plc
13/07/202118:02UK RegulatoryEvgen Pharma PLC Result of AGM and Business UpdateLSE:EVGEvgen Pharma Plc
13/07/202115:09Alliance NewsAlliance NewsIN BRIEF: Evgen Pharma files brain tumour treatment request with FDALSE:EVGEvgen Pharma Plc
13/07/202112:25Alliance NewsAlliance NewsIN BRIEF: Evgen Pharma encouraged by early data for SFX-01LSE:EVGEvgen Pharma Plc
13/07/202108:00UK RegulatoryEvgen Pharma PLC Glioma Orphan Drug application submitted to US FDALSE:EVGEvgen Pharma Plc
13/07/202108:00RNS Non-RegulatoryEvgen Pharma PLC Early data for SFX-01 in leukaemia cell linesLSE:EVGEvgen Pharma Plc
09/07/202112:51Alliance NewsAlliance NewsEvgen Pharma halts trial as SFX-01 drug fails to help Covid patientsLSE:EVGEvgen Pharma Plc
09/07/202108:00UK RegulatoryEvgen Pharma PLC Interim Safety and Futility Analysis - STAR trialLSE:EVGEvgen Pharma Plc
18/06/202108:00UK RegulatoryEvgen Pharma PLC Posting of Annual Report and Notice of AGMLSE:EVGEvgen Pharma Plc
15/06/202115:42Alliance NewsAlliance NewsTRADING UPDATES: GB Group rebuilds dividend; IPF ups 2021 profit viewLSE:EVGEvgen Pharma Plc
15/06/202108:00UK RegulatoryEvgen Pharma PLC Final ResultsLSE:EVGEvgen Pharma Plc
14/06/202114:19Alliance NewsAlliance NewsTRADING UPDATES: Synectics loss narrows; Active Energy loss widensLSE:EVGEvgen Pharma Plc
14/06/202108:00UK RegulatoryEvgen Pharma PLC Progress with Glioma/Glioblastoma programmeLSE:EVGEvgen Pharma Plc
14/06/202108:00UK RegulatoryEvgen Pharma PLC Progress on metastatic breast cancer programmeLSE:EVGEvgen Pharma Plc
26/04/202114:02Alliance NewsAlliance NewsIN BRIEF: Evgen Pharma appoints Huw Jones as chief medical officerLSE:EVGEvgen Pharma Plc
26/04/202108:00UK RegulatoryEvgen Pharma PLC Appointment of Chief Medical OfficerLSE:EVGEvgen Pharma Plc
07/04/202117:22Alliance NewsAlliance NewsIN BRIEF: Evgen Pharma notes publication on sulforaphane in Covid-19LSE:EVGEvgen Pharma Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network